Literature DB >> 21741611

Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth.

Pekka Nieminen1, Neil V Morgan, Aimée L Fenwick, Satu Parmanen, Lotta Veistinen, Marja L Mikkola, Peter J van der Spek, Andrew Giraud, Louise Judd, Sirpa Arte, Louise A Brueton, Steven A Wall, Irene M J Mathijssen, Eamonn R Maher, Andrew O M Wilkie, Sven Kreiborg, Irma Thesleff.   

Abstract

Craniosynostosis and supernumerary teeth most often occur as isolated developmental anomalies, but they are also separately manifested in several malformation syndromes. Here, we describe a human syndrome featuring craniosynostosis, maxillary hypoplasia, delayed tooth eruption, and supernumerary teeth. We performed homozygosity mapping in three unrelated consanguineous Pakistani families and localized the syndrome to a region in chromosome 9. Mutational analysis of candidate genes in the region revealed that all affected children harbored homozygous missense mutations (c.662C>G [p.Pro221Arg], c.734C>G [p.Ser245Cys], or c.886C>T [p.Arg296Trp]) in IL11RA (encoding interleukin 11 receptor, alpha) on chromosome 9p13.3. In addition, a homozygous nonsense mutation, c.475C>T (p.Gln159X), and a homozygous duplication, c.916_924dup (p.Thr306_Ser308dup), were observed in two north European families. In cell-transfection experiments, the p.Arg296Trp mutation rendered the receptor unable to mediate the IL11 signal, indicating that the mutation causes loss of IL11RA function. We also observed disturbed cranial growth and suture activity in the Il11ra null mutant mice, in which reduced size and remodeling of limb bones has been previously described. We conclude that IL11 signaling is essential for the normal development of craniofacial bones and teeth and that its function is to restrict suture fusion and tooth number. The results open up the possibility of modulation of IL11 signaling for the treatment of craniosynostosis.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741611      PMCID: PMC3135804          DOI: 10.1016/j.ajhg.2011.05.024

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  55 in total

1.  Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis.

Authors:  H H Nandurkar; L Robb; D Tarlinton; L Barnett; F Köntgen; C G Begley
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

2.  Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.

Authors:  S Mundlos; F Otto; C Mundlos; J B Mulliken; A S Aylsworth; S Albright; D Lindhout; W G Cole; W Henn; J H Knoll; M J Owen; R Mertelsmann; B U Zabel; B R Olsen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

Review 3.  Supernumerary and congenitally absent teeth: a literature review.

Authors:  J F Zhu; M Marcushamer; D L King; R J Henry
Journal:  J Clin Pediatr Dent       Date:  1996       Impact factor: 1.065

Review 4.  Tooth eruption: theories and facts.

Authors:  S C Marks; H E Schroeder
Journal:  Anat Rec       Date:  1996-06

5.  Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development.

Authors:  D P Rice; H J Kim; I Thesleff
Journal:  Bone       Date:  1997-12       Impact factor: 4.398

6.  Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis.

Authors:  X Du; E T Everett; G Wang; W H Lee; Z Yang; D A Williams
Journal:  J Cell Physiol       Date:  1996-08       Impact factor: 6.384

7.  Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation.

Authors:  L Robb; R Li; L Hartley; H H Nandurkar; F Koentgen; C G Begley
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

8.  Interleukin (IL)-11--mediated signal transduction.

Authors:  Y C Yang; T Yin
Journal:  Ann N Y Acad Sci       Date:  1995-07-21       Impact factor: 5.691

9.  Etl2, a novel putative type-I cytokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential.

Authors:  H Neuhaus; B Bettenhausen; P Bilinski; D Simon-Chazottes; J L Guénet; A Gossler
Journal:  Dev Biol       Date:  1994-12       Impact factor: 3.582

10.  The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.

Authors:  E Romas; N Udagawa; H Zhou; T Tamura; M Saito; T Taga; D J Hilton; T Suda; K W Ng; T J Martin
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

View more
  60 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  Mutation Screening of Candidate Genes in Patients with Nonsyndromic Sagittal Craniosynostosis.

Authors:  Xiaoqian Ye; Audrey Guilmatre; Boris Reva; Inga Peter; Yann Heuzé; Joan T Richtsmeier; Deborah J Fox; Rhinda J Goedken; Ethylin Wang Jabs; Paul A Romitti
Journal:  Plast Reconstr Surg       Date:  2016-03       Impact factor: 4.730

Review 3.  The genetic basis of pneumococcal and staphylococcal infections: inborn errors of human TLR and IL-1R immunity.

Authors:  Bertrand Boisson
Journal:  Hum Genet       Date:  2020-01-24       Impact factor: 4.132

Review 4.  The role of vertebrate models in understanding craniosynostosis.

Authors:  Greg Holmes
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

Review 5.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

6.  Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome.

Authors:  Natalia I Dmitrieva; Avram D Walts; Dai Phuong Nguyen; Alex Grubb; Xue Zhang; Xujing Wang; Xianfeng Ping; Hui Jin; Zhen Yu; Zu-Xi Yu; Dan Yang; Robin Schwartzbeck; Clifton L Dalgard; Beth A Kozel; Mark D Levin; Russell H Knutsen; Delong Liu; Joshua D Milner; Diego B López; Michael P O'Connell; Chyi-Chia Richard Lee; Ian A Myles; Amy P Hsu; Alexandra F Freeman; Steven M Holland; Guibin Chen; Manfred Boehm
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

7.  Sox2 marks epithelial competence to generate teeth in mammals and reptiles.

Authors:  Emma Juuri; Maria Jussila; Kerstin Seidel; Scott Holmes; Ping Wu; Joy Richman; Kristiina Heikinheimo; Cheng-Ming Chuong; Katrin Arnold; Konrad Hochedlinger; Ophir Klein; Frederic Michon; Irma Thesleff
Journal:  Development       Date:  2013-03-05       Impact factor: 6.868

8.  Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.

Authors:  Amy P Hsu; Kathryn J Sowerwine; Monica G Lawrence; Joie Davis; Carolyn J Henderson; Kol A Zarember; Mary Garofalo; John I Gallin; Douglas B Kuhns; Theo Heller; Joshua D Milner; Jennifer M Puck; Alexandra F Freeman; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2013-04-25       Impact factor: 10.793

9.  Continuous dental replacement in a hyper-chisel tooth digging rodent.

Authors:  Helder Gomes Rodrigues; Pauline Marangoni; Radim Šumbera; Paul Tafforeau; Wim Wendelen; Laurent Viriot
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

10.  An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis.

Authors:  Marian Seda; Maartje Geerlings; Peggy Lim; Jeshmi Jeyabalan-Srikaran; Ann-Christin Cichon; Peter J Scambler; Philip L Beales; Victor Hernandez-Hernandez; Andrew W Stoker; Dagan Jenkins
Journal:  Mol Syndromol       Date:  2018-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.